{"url_path":"/sec/abeo/8-k/2026-06-10/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-10","source_url":"https://www.sec.gov/Archives/edgar/data/318306/0001493152-26-028106-index.html","accession_number":"0001493152-26-028106","cik":"0000318306","ticker":"ABEO","issuer_name":"ABEONA THERAPEUTICS INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/318306/0001493152-26-028106-index.html","primary_entity_key":"0000318306","primary_entity_name":"ABEONA THERAPEUTICS INC."},"word_count":143,"has_tables":true,"body_markdown":"**Item\n7.01. Regulation FD Disclosure.**\n\n \n\nAbeona\nTherapeutics Inc. is furnishing in this Current Report on Form 8-K an updated investor presentation (the “Investor Presentation”)\nthat it expects to use, either in whole or in part, in connection with presentations to investors, analysts, and others. A copy of the\nInvestor Presentation is furnished herewith as Exhibit 99.1 and is incorporated into this Item 7.01 by reference.\n\n \n\nThe\ninformation in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed “filed”\nfor purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section,\nnor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as expressly set\nforth by specific reference in such a filing."}